SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1927<i> ReadMeFirst</i> updated for termination of M249, an undisclosed DewDiligence_on_SI-12/23/2008
1926<i>ReadMeFirst</i> updated for $24M private placement and latest FTYDewDiligence_on_SI-12/12/2008
1925<i>ReadMeFirst</i> updated for $24M private placement: siliconinvesDewDiligence_on_SI-12/12/2008
1924>>Hedging their bets on a fast m-lovenox approval? I would. Now is the tIRWIN JAMES FRANKEL-12/12/2008
1923Hedging their bets on a fast m-lovenox approval? Press Release Source: Momentarkrw-12/12/2008
1922<i>ReadMeFirst</i> updated: Anticoagulant index (competition); musiDewDiligence_on_SI-12/11/2008
1921My take on MRK’s FoB program (FWIW): siliconinvestor.com siliconinvestor.com siDewDiligence_on_SI-12/9/2008
1920Watch out Amgen and Genentech, Merck wants a piece of your business. blogs.wsj.cnigel bates-12/9/2008
1919New CoB: siliconinvestor.comDewDiligence_on_SI-12/5/2008
1918<i>ReadMeFirst</i> updated: New section of on likelihood of a LovenDewDiligence_on_SI-11/30/2008
1917<i>ReadMeFirst</i> updated: musings on economics of the Lovenox collDewDiligence_on_SI-11/27/2008
1916<b>Rep. Dingell and FoB Legislation</b> The recently announced oustDewDiligence_on_SI-11/23/2008
1915Correct (eom).DewDiligence_on_SI-11/23/2008
191410b51 plan? I noticed he sold a small amount of shares recently per the plan. Anrkrw-11/23/2008
1913Quiz: What does CFO Rick Shea have in common with SVP John Bishop and directors DewDiligence_on_SI-11/23/2008
1912Yes.idos-11/17/2008
1911Sounds like scratch them as a serious competitor. rkrw-11/17/2008
1910My understanding is that Procognia's technique doesn't give a greater/beidos-11/17/2008
1909Hard to say. Generic companies are used to being really quiet. Quick look on trkrw-11/16/2008
1908Procognia (#msg-22829411). Teva has said virtually nothing about this allianceDewDiligence_on_SI-11/16/2008
1907I'm sure there's more serious competition out there. Teva was partnered rkrw-11/16/2008
1906Competition? You be the judge: siliconinvestor.comDewDiligence_on_SI-11/16/2008
1905>Does anyone know the court where the case is filed?< The lawsuit was filidos-11/15/2008
1904>>Teva has repeatedly asserted that a "full-fledged clinical study&quIRWIN JAMES FRANKEL111/14/2008
1903<i>Article reads like the patent should be invalid regardless of intent.&lDewDiligence_on_SI-11/14/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News